110 related articles for article (PubMed ID: 30828792)
41. Family screening in medullary thyroid carcinoma presenting without a family history.
Ponder BA; Finer N; Coffey R; Harmer CL; Maisey M; Ormerod MG; Pembrey ME; Ponder MA; Rosswick P; Shalet S
Q J Med; 1988 Apr; 67(252):299-308. PubMed ID: 2905066
[TBL] [Abstract][Full Text] [Related]
42. Clinical case seminar: in vivo and in vitro characterization of a novel germline RET mutation associated with low-penetrant nonaggressive familial medullary thyroid carcinoma.
D'Aloiso L; Carlomagno F; Bisceglia M; Anaganti S; Ferretti E; Verrienti A; Arturi F; Scarpelli D; Russo D; Santoro M; Filetti S
J Clin Endocrinol Metab; 2006 Mar; 91(3):754-9. PubMed ID: 16384843
[TBL] [Abstract][Full Text] [Related]
43. Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas.
Toledo RA; Qin Y; Cheng ZM; Gao Q; Iwata S; Silva GM; Prasad ML; Ocal IT; Rao S; Aronin N; Barontini M; Bruder J; Reddick RL; Chen Y; Aguiar RC; Dahia PL
Clin Cancer Res; 2016 May; 22(9):2301-10. PubMed ID: 26700204
[TBL] [Abstract][Full Text] [Related]
44. Medullary thyroid cancer, leukemia, mesothelioma and meningioma associated with germline APC and RASAL1 variants: a new syndrome?
Angelousi A; Settas N; Faucz FR; Lyssikatos C; Quezado M; Nasiri-Ansari N; Stratakis CA; Kassi E
Hormones (Athens); 2017 Oct; 16(4):423-428. PubMed ID: 29518763
[TBL] [Abstract][Full Text] [Related]
45. Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series.
Alsanea O; Wada N; Ain K; Wong M; Taylor K; Ituarte PH; Treseler PA; Weier HU; Freimer N; Siperstein AE; Duh QY; Takami H; Clark OH
Surgery; 2000 Dec; 128(6):1043-50;discussion 1050-1. PubMed ID: 11114641
[TBL] [Abstract][Full Text] [Related]
46. [Medullary thyroid carcinoma--familial or sporadic disease?].
Høie J; Jørgensen OG; Nesland JM; Møller P; Bjøro K
Tidsskr Nor Laegeforen; 1994 Oct; 114(25):2951-4. PubMed ID: 7974404
[TBL] [Abstract][Full Text] [Related]
47. Various penetrance of familial medullary thyroid carcinoma in patients with RET protooncogene codon 790/791 germline mutations.
Fitze G; Schierz M; Bredow J; Saeger HD; Roesner D; Schackert HK
Ann Surg; 2002 Nov; 236(5):570-5. PubMed ID: 12409662
[TBL] [Abstract][Full Text] [Related]
48. Emergence of medullary thyroid carcinoma in a family with the Cys630Arg RET germline mutation.
Machens A; Schneyer U; Holzhausen HJ; Raue F; Dralle H
Surgery; 2004 Nov; 136(5):1083-7. PubMed ID: 15523405
[TBL] [Abstract][Full Text] [Related]
49. [Medullary thyroid cancer - the present state of art].
Krysiak R; Marek B; Okopień B
Endokrynol Pol; 2008; 59(5):446-55. PubMed ID: 18979455
[TBL] [Abstract][Full Text] [Related]
50. Analysis of Newly Identified and Rare Synonymous Genetic Variants in the RET Gene in Patients with Medullary Thyroid Carcinoma in Polish Population.
Sromek M; Czetwertyńska M; Tarasińska M; Janiec-Jankowska A; Zub R; Ćwikła M; Nowakowska D; Chechlińska M
Endocr Pathol; 2017 Sep; 28(3):198-206. PubMed ID: 28647780
[TBL] [Abstract][Full Text] [Related]
51. Familial medullary thyroid carcinoma and prominent corneal nerves associated with the germline V804M and V778I mutations on the same allele of RET.
Kasprzak L; Nolet S; Gaboury L; Pavia C; Villabona C; Rivera-Fillat F; Oriola J; Foulkes WD
J Med Genet; 2001 Nov; 38(11):784-7. PubMed ID: 11732489
[No Abstract] [Full Text] [Related]
52. HABP2 in Familial Non-medullary Thyroid Cancer: Will the Real Mutation Please Stand Up?
Ngeow J; Eng C
J Natl Cancer Inst; 2016 Jun; 108(6):djw013. PubMed ID: 26832774
[No Abstract] [Full Text] [Related]
53. Genome-wide copy number imbalances identified in familial and sporadic medullary thyroid carcinoma.
Marsh DJ; Theodosopoulos G; Martin-Schulte K; Richardson AL; Philips J; Röher HD; Delbridge L; Robinson BG
J Clin Endocrinol Metab; 2003 Apr; 88(4):1866-72. PubMed ID: 12679485
[TBL] [Abstract][Full Text] [Related]
54. A novel germ-line point mutation in RET exon 8 (Gly(533)Cys) in a large kindred with familial medullary thyroid carcinoma.
Da Silva AM; Maciel RM; Da Silva MR; Toledo SR; De Carvalho MB; Cerutti JM
J Clin Endocrinol Metab; 2003 Nov; 88(11):5438-43. PubMed ID: 14602786
[TBL] [Abstract][Full Text] [Related]
55. [Medullary cancer of the thyroid].
Calmettes C
Bull Cancer; 1990; 77(11):1063-72. PubMed ID: 2275984
[TBL] [Abstract][Full Text] [Related]
56. Targeted DNA Sequencing Detects Mutations Related to Susceptibility among Familial Non-medullary Thyroid Cancer.
Yu Y; Dong L; Li D; Chuai S; Wu Z; Zheng X; Cheng Y; Han L; Yu J; Gao M
Sci Rep; 2015 Nov; 5():16129. PubMed ID: 26530882
[TBL] [Abstract][Full Text] [Related]
57. [Thyroid C cells and their pathology: Part 1: normal C cells, - C cell hyperplasia, - precursor of familial medullary thyroid carcinoma].
Ting S; Synoracki S; Schmid KW
Pathologe; 2015 May; 36(3):246-53. PubMed ID: 25898937
[TBL] [Abstract][Full Text] [Related]
58. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".
Fink M; Weinhüsel A; Niederle B; Haas OA
Int J Cancer; 1996 Aug; 69(4):312-6. PubMed ID: 8797874
[TBL] [Abstract][Full Text] [Related]
59. [Medullary thyroid carcinoma: clinical and oncological features and treatment].
Puñales MK; Rocha AP; Gross JL; Maia AL
Arq Bras Endocrinol Metabol; 2004 Feb; 48(1):137-46. PubMed ID: 15611826
[TBL] [Abstract][Full Text] [Related]
60. [Germline mutations of the ret proto-oncogene in Chilean patients with hereditary and sporadic medullary thyroid carcinoma].
Wohllk N; Becker P; Youlton R; Cote GJ; Gagel RF
Rev Med Chil; 2001 Jul; 129(7):713-8. PubMed ID: 11552438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]